AI/PDE data sharing initiative announces release of new data records to streamline pharmaceutical risk assessment workflows
- October 1, 2024
Lhasa Limited is pleased to announce the release of new data to the Vitic AI/PDE database.
This pre-competitive data sharing initiative facilitates anonymous sharing of AI/PDE data from pharmaceutical organisations.
Lhasa Limited elevates genotoxicity assessment with new chromosome damage prediction model
- August 30, 2024
Lhasa Limited is excited to announce a significant enhancement to Sarah Nexus, with the introduction of a new chromosome damage prediction model.
Introducing enhanced toxicity data for safer chemical risk assessments: Vitic database release
- August 21, 2024
Lhasa Limited is pleased to announce the release of the Vitic 2024.1 database, supporting organisations leading the way in the pharmaceutical, cosmetic, and agrochemical industries, with toxicity risk assessments.
Lhasa Limited launches Kaptis 2: Bridging the gap between non-animal studies and confident safety assessments
- August 9, 2024
Lhasa Limited is thrilled to announce the launch of Kaptis 2. Kaptis is an in silico solution that is supporting organisations to more efficiently evaluate compound carcinogenic potential, whilst building more ethical and environmentally friendly assessments.
Recent database release continues to improve understanding of complex nitrosamine structure-activity relationships (SARs)
- August 6, 2024
Lhasa Limited is delighted to announce the sixth release of new data to the Vitic Complex Nitrosamines database.
This pre-competitive data sharing initiative facilitates the anonymous sharing of Ames data on structurally complex nitrosamines to improve understanding of their structure-activity-relationships (SARs).
Developments continue within the Lhasa Intermediates data sharing initiative enhancing risk assessments
- June 18, 2024
Lhasa Limited is delighted to announce the release of new data to the Vitic Intermediates database.
This pre-competitive data sharing initiative facilitates anonymous sharing of Ames mutagenicity results, for common intermediates and compounds containing functional groups of interest.
Driving confidence in decisions: Updates to the Lhasa Carcinogenicity Database
- June 12, 2024
Lhasa Limited is pleased to announce new software updates to the Lhasa Carcinogenicity Database (LCDB), a freely available source of long-term carcinogenicity data.
Lhasa Limited release Zeneth 10, now with prediction types: Streamlined nitrosamine risk assessment
- April 4, 2024
Lhasa Limited is pleased to announce the release of Zeneth 10.0.0, featuring multiple updates including differing prediction types: Structure-based or nitrosamine risk assessment.
Introducing In Vivo data to the Complex Nitrosamine data sharing initiative
- March 28, 2024
Lhasa Limited is thrilled to announce the 5th release of the Vitic Complex Nitrosamine database, which has been expanded to include, for the first time, in vivo genotoxicity data.
Lhasa Limited release Acrostic: A revolutionary read-across tool for assessing nitrosamine carcinogenicity
- March 13, 2024
Lhasa Limited is pleased to announce the release of Acrostic, a cutting-edge read-across tool designed to enhance decision-making in establishing acceptable intake (AI) limits for novel and untested nitrosamines.